Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Repair of Brain Injury After Whole CNS Radiotherapy in Children With Medulloblastoma
ChiCTR2500103242Phase 4Not yet recruiting
- Sponsor
- Shenzhen Children's Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in medulloblastoma, radiation-induced encephalopathy (RIE) and Radiation-induced cognitive dysfunction (RICD) (2 arms), sponsored by Shenzhen Children's Hospital. Primary endpoint: Neuroimaging measurement results. Planned start May 2025; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
medulloblastomaradiation-induced encephalopathy (RIE)Radiation-induced cognitive dysfunction (RICD)
Beyond the preview
Go deeper on ChiCTR2500103242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103242.